
What We're Reading: Revisiting Standards of Pain Management
What we're reading, April 18, 2016: medical experts ask the Joint Commission to revisit its standards of pain management; study determines low-cost generics just as effective at treating hepatitis C as brand name drugs; and UnitedHealth also pulling out of Michigan Obamacare exchange.
Nonprofit groups and medical experts have asked the Joint Commission to revisit its standards of pain management.
Last week, UnitedHealth announced that it would pull out of the Affordable Care Act (ACA) exchanges
A new study has determined that low-cost generic drugs are just as safe and effective for treating hepatitis C as the expensive brand name versions. The brand name drugs cost as much as $94,000 a patient, while the generic versions cost less than 1% of that,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.